HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Nina Eissler Selected Research

9-O-acetyl-GD3 ganglioside

11/2012Ganglioside GD2-specific trifunctional surrogate antibody Surek demonstrates therapeutic activity in a mouse melanoma model.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Nina Eissler Research Topics

Disease

8Neoplasms (Cancer)
06/2018 - 08/2012
4Neuroblastoma
11/2021 - 01/2016
3Melanoma (Melanoma, Malignant)
08/2015 - 08/2012
1Medulloblastoma
11/2021
1Inflammation (Inflammations)
06/2018

Drug/Important Bio-Agent (IBA)

4Bispecific AntibodiesIBA
08/2015 - 08/2012
2Macrophage Colony-Stimulating FactorIBA
01/2016 - 01/2016
24- (2- (2- hydroxycyclohexylamino)benzothiazol- 6- yloxy)pyridine- 2- carboxylic acid methylamideIBA
01/2016 - 01/2016
2GD2 gangliosideIBA
08/2015 - 08/2012
2AntigensIBA
04/2013 - 08/2012
2Immunoglobulin Fc FragmentsIBA
04/2013 - 08/2012
1SL-176IBA
11/2021
1nutlin 3IBA
11/2021
1Dinoprostone (PGE2)FDA Link
06/2018
1Prostaglandin-E SynthasesIBA
06/2018
1Pharmaceutical PreparationsIBA
06/2018
1Blocking AntibodiesIBA
01/2016
1Therapeutic UsesIBA
01/2016
1ChemokinesIBA
01/2016
1Semaphorins (Semaphorin)IBA
07/2013
1Immunoglobulin G (IgG)IBA
11/2012
1GangliosidesIBA
11/2012
1AntibodiesIBA
11/2012
19-O-acetyl-GD3 gangliosideIBA
11/2012
1Peptides (Polypeptides)IBA
08/2012
1InterferonsIBA
08/2012

Therapy/Procedure

4Immunotherapy
01/2016 - 08/2012
1Therapeutics
06/2018
1Combined Modality Therapy
01/2016
1Intravenous Administration
08/2015